Sort
30,917 grants matching “tumor microenvironment”
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
$530,360Elizabeth Marion Jaffee · Johns Hopkins University · R01 · FY2024 · CA
Adoptive T Cell Therapy for the Treatment of HER2 Overexpressing Cancers
$530,353Mary L. Disis · University Of Washington · R01 · FY2011 · CA
A pH Responsive Transistor-like Nanoprobe for Sensitive Detection of Unknown Primary Cancers of the Head and Neck
$530,327Baran D Sumer · Ut Southwestern Medical Center · R01 · FY2022 · CA
A pro-metastatic secretory pathway activated by p53 loss in lung cancer
$530,294Jonathan M Kurie · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Regulation of Androgen Receptor by NXTAR Long non-coding RNA in Prostate Cancer and its Therapeutic Implications
$530,267Nupam P Mahajan · Washington University · R01 · FY2025 · CA
Mechanistic insights on structure, topology and radiation effects on RNA nanomedicines
$530,230Conroy Ghin Chee Sun · Oregon State University · R01 · FY2024 · CA
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
$530,090Tyler J. Curiel · University Of Texas Hlth Science Center · R01 · FY2019 · CA
The Role of the Amino Acid Hypusine in the Maintenance and Function of Tissue-Resident Macrophages
$530,018Erika L Pearce · Johns Hopkins University · R01 · FY2023 · AI
Dissecting the immunomodulatory effects of NK cells on immune responses to cancer
$530,015Kevin C Barry · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Project 1-Combination Immunotherapy with Radioligned Therapy for Metastatic Prostate Cancer
$529,989Lawrence Fong · University Of California, San Francisco · P50 · FY2025 · CA
Targeting RAGE in tumor and TME to oppose inflammation and drug resistance in obesity associated ER+ breast cancer
$529,962Barry Ian Hudson · Georgetown University · R01 · FY2025 · CA
Preclinical microphysiological tumor models for nuclear medicine
$529,906Guillem Pratx · Stanford University · R01 · FY2023 · CA
Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunology
$529,878Nikhil Joshi · Yale University · R01 · FY2024 · CA
Project 1 Mouse Models Analysis
$529,826Edgar G. Engleman · Stanford University · U54 · FY2025 · CA
Co-evolution of the Reactive Microenvironment in Prostate Cancer Progression
$529,800David R Rowley · Baylor College Of Medicine · U54 · FY2008 · CA
(PQ7) In Vivo Cellular Optical Imaging of Esophageal Tumors and Microenvironment
$529,795Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2017 · CA
Cell-Selective CpG-STAT3 Inhibitors for Radioimmunotherapy of Malignant Glioma
$529,603Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA
Research Test-Bed Unit
$529,581Daniela E Matei · Northwestern University · U54 · FY2024 · CA
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
$529,533Chi V. Dang · Johns Hopkins University · R01 · FY2024 · CA
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma
$529,462Jinming Gao · Ut Southwestern Medical Center · U01 · FY2020 · CA
Signal Transduction by Non-Transmembrane PTPs
$529,389Benjamin G. Neel · New York University School Of Medicine · R01 · FY2016 · CA
Signal Transduction by Non-Transmembrane PTPs
$529,389Benjamin G. Neel · New York University School Of Medicine · R01 · FY2020 · CA
Signal Transduction by Non-Transmembrane PTPs
$529,389Benjamin G. Neel · New York University School Of Medicine · R01 · FY2017 · CA
Fluorescent Indocarbocyanine PEGylated Lipid Nanoparticles for Understanding and Overcoming Barriers to Drug Delivery in Invasive Glioblastoma
$529,375Dmitri Simberg · University Of Colorado Denver · R01 · FY2025 · CA
Targeting Hypoxia-Induced Cancer-Cell Adaptation by Direct Inhibition of Akt and
$529,342Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2013 · CA